Ceres Ventures (CEVE) Return on Equity ROE from the third quarter 2012 to third quarter 2011 and annually, average high and low, overall ranking from Sep 30 2012 to Sep 30 2011 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Ceres Ventures, Inc.  (CEVE)

Ceres Ventures's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Ceres Ventures in the third quarter 2012?
Due to the lack of equity, it was not possible to calculate Ceres Ventures, Inc.'s return on equity (ROE) in its third quarter 2012

What is ROE?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Equity (Sep 30 2012)
III. Quarter		 (Jun 30 2012)
II. Quarter		 (Mar 31 2012)
I. Quarter		 (Dec 31 2011)
IV. Quarter		 (Sep 30 2011)
III. Quarter
Y / Y Equity Change - - - - -
Y / Y Net Income Change - - - - -
Net Income (TTM) in Millions 0 0 0 0 0
Return On Equity (TTM) - - - - -
CEVE's Total Ranking # # # # #
Equity (TTM) in Millions 0 0 0 0 0
Seq. Equity Change - - - - -
Seq. Net Income Change - - - - -

Back to CEVE Management Effectiveness >> CEVE's 5 Years Annual ROE >> Compare CEVE ROE to its Competitors
Return On Equity Company Ranking
Within: No.
Industry #
Sector #
Overall #

Return On Equity Statistics
High Average Low
0 %
0 %
0 %
 





CEVE Annual Return On Equity (Dec 31 2011)
2011



Total Equity in Millions 0 0 0 0 0
Y / Y Equity Change - - - - -
Net Income in Millions -1 0 0 0 0
Y / Y Net Income Change - - - - -
Return On Equity - - - - -

Back to CEVE Management Effectiveness >> CEVE's 5 Years Annual ROE >> Compare CEVE ROE to its Competitors




More Return On Equity Ratios
Major Pharmaceutical Preparations Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
CEVE's' Return on Equity at Yahoo Finance
CEVE's Roe Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for CEVE's Competitors
Subscribers only: Roe for Ceres Ventures's Suppliers
Subscribers only: Return On Equity for CEVE's Customers




Companies with similar Return On Equity at Sep 30 2012, within Healthcare Sector ROE
Biocardia Inc   111.94 %
Encompass Health Corporation  87.97 %
Fonar Corporation  79.51 %
Precision Optics Corporation Inc   72.56 %
Ligand Pharmaceuticals Incorporated  62.05 %
Pacific Health Care Organization Inc  57.84 %
Lifevantage Corp  54.78 %
China Health Industries Holdings Inc   40.48 %
Spectrum Pharmaceuticals Inc   38.86 %
Regeneron Pharmaceuticals Inc   37.89 %
Mettler toledo International Inc   35.49 %
Baxter International Inc   33.84 %
Waters Corporation  33.11 %
Gilead Sciences Inc   31.89 %
Idexx Laboratories Inc  31.40 %
Nature s Sunshine Products inc   28.67 %
Varian Medical Systems Inc   28.25 %
Celgene Corp  28.24 %
Eli Lilly And Company  28.06 %
Bard C R Inc  27.60 %
United Therapeutics Corporation  27.23 %
Abbott Laboratories  26.38 %
Becton Dickinson And Company  26.27 %
3m Company  26.24 %
Option Care Health Inc   25.48 %
Abbvie Inc   24.93 %
Agilent Technologies inc   23.93 %
U S Physical Therapy Inc  23.92 %
Meridian Bioscience Inc   23.74 %
Davita Inc   23.32 %

Date modified: 2026-09-08T15:07:17+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.